Abstract
Deregulation of apoptosis is responsible for diseases that involve defects in the death pathway, such as neoplasias, or in its inhibition, like degenerative processes. Among apoptosis- regulating molecules, a role is emerging for BAG3, a member of the BAG proteins family (BAG1L, BAG1, BAG2, BAG3, BAG4. BAG5 and BAG6) involved in cochaperoning of heat shock proteins. Through its BAG, WW and prolix-rich domains, BAG3 protein can interact with a variety of molecular partners, including Hsc70/Hsp70, phospholipase C-γ and others. It has been recently shown that, in human primary lymphoid and myeloblastic leukemias, thyroid carcinoma and other human tumors, BAG3 expression sustains cell survival and impairs cell response to therapy. This review discusses two patents concerning, respectively, BAG3 and other Hsc70/Hsp70 co-chaperones, namely HspBP-1 and HspBP-2.
Keywords: Apoptosis, cell survival, co-chaperone
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title: Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones
Volume: 3 Issue: 2
Author(s): Anna Basile, Morena d'Avenia, Alessandra Rosati, Michelina Festa, Antonia Falco, Maria C. Turco and Maria Pascale
Affiliation:
Keywords: Apoptosis, cell survival, co-chaperone
Abstract: Deregulation of apoptosis is responsible for diseases that involve defects in the death pathway, such as neoplasias, or in its inhibition, like degenerative processes. Among apoptosis- regulating molecules, a role is emerging for BAG3, a member of the BAG proteins family (BAG1L, BAG1, BAG2, BAG3, BAG4. BAG5 and BAG6) involved in cochaperoning of heat shock proteins. Through its BAG, WW and prolix-rich domains, BAG3 protein can interact with a variety of molecular partners, including Hsc70/Hsp70, phospholipase C-γ and others. It has been recently shown that, in human primary lymphoid and myeloblastic leukemias, thyroid carcinoma and other human tumors, BAG3 expression sustains cell survival and impairs cell response to therapy. This review discusses two patents concerning, respectively, BAG3 and other Hsc70/Hsp70 co-chaperones, namely HspBP-1 and HspBP-2.
Export Options
About this article
Cite this article as:
Basile Anna, d'Avenia Morena, Rosati Alessandra, Festa Michelina, Falco Antonia, Turco C. Maria and Pascale Maria, Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2009; 3 (2) . https://dx.doi.org/10.2174/187221409788452318
DOI https://dx.doi.org/10.2174/187221409788452318 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Fiber-Optic Technologies in Laser-Based Therapeutics: Threads for a Cure
Current Pharmaceutical Biotechnology Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents
Current Drug Therapy Pericyte: Potential Target for Hemorrhagic Stroke Prevention and Treatment
Current Drug Delivery bmp3 is Required for Integrity of Blood Brain Barrier by Promoting Pericyte Coverage in Zebrafish Embryos
Current Molecular Medicine Management of Hypertension in the Acute Phase of Stroke
Current Hypertension Reviews Current Management of Neonatal Liver Tumors
Current Pediatric Reviews Heart Transplantation for Congenital Heart Disease in the First Year of Life
Current Cardiology Reviews Circulating Endothelial Progenitor Cells Biology and Regenerative Medicine in Pulmonary Vascular Diseases
Current Pharmaceutical Biotechnology ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis
Current Vascular Pharmacology Prevention of Intracerebral Haemorrhage
Current Drug Targets Multitarget Network Strategies to Influence Memory and Forgetting: The Ras/Mapk Pathway as a Novel Option
Mini-Reviews in Medicinal Chemistry Novel Application of Plasma Treatment for Pharmaceutical and Biomedical Engineering
Current Drug Discovery Technologies Emerging Role of Bone Morphogenetic Proteins as a Context Dependent Pro-Angiogenic Cue
Current Angiogenesis (Discontinued) A Review of Artificial Intelligence in Cerebrovascular Disease Imaging: Applications and Challenges
Current Neuropharmacology Vasculogenesis: Making Pipes for the Cardiovascular Plumbing
Current Angiogenesis (Discontinued) Remodelling of the Ca2+ Toolkit in Tumor Endothelium as a Crucial Responsible for the Resistance to Anticancer Therapies
Current Signal Transduction Therapy Why and how do Microbubbles Enhance the Effectiveness of Diagnostic and Therapeutic Interventions in Cerebrovascular Disease?
Current Pharmaceutical Design Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued) Protective Effect of Vitamin B Therapy on Bone and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery